1-4 of 4
Matthew R. Youngman, BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Primary Mediastinal B-Cell Lymphoma: Evaluation of Clinicopathologic Diagnosis Compared to Gene Expression Based Diagnosis in a Clinical Trial with CD30+ B-Cell Lymphomas

Jakub Svoboda, MD, Steven M. Bair, MD, Christian Steidl, MD, Marco Ruella, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Stefan Klaus Barta, MD MRCP, MS, M. Reza Nejati, MD, James Nathan Gerson, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Elise A. Chong, MD, Olga Kutovaya, PhD, Stacy Hung, Agata M. Bogusz, MD PhD, Megan S. Lim, MD, PhD, Stephen J. Schuster, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2959.
https://doi.org/10.1182/blood-2018-99-115024
Published: 2018
Journal Articles

Pilot Study of Non-Viral, RNA-Redirected Autologous Anti-CD19 Chimeric Antigen Receptor Modified T-Cells in Patients with Refractory/Relapsed Hodgkin Lymphoma (HL)

Jakub Svoboda, MD, Susan R. Rheingold, MD, Saar I Gill, MD PhD, Stephan A Grupp, MD PhD, Simon F Lacey, PhD BS, J. Joseph Melenhorst, PhD, Irina Kulikovskaya, Brandon Loudon, Naseem Kerr, MPH, Katherine T Marcucci, PhD, Kim-Marie Shea, RN, Aliza Schmidt, MS, Lester Lledo, RN,MSN,CNP, Amy Marshall, Anthony R. Mato, MD, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Matthew R. Youngman, BS, Bruce L Levine, PhD, David L Porter, MD, Carl H June, MD, Stephen J. Schuster, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 653.
https://doi.org/10.1182/blood.V130.Suppl_1.653.653
Published: 2017
Journal Articles

Clinical Outcomes of Anti PD-1 Immunotherapy in Patients with Relapsed/Refractory Non Hodgkin Lymphomas

Mitchell E. Hughes, PharmD, BCPS, BCOP, Christopher Jensen, MD, Jakub Svoboda, MD, Lauren Elizabeth Strelec, BA, Matthew R. Youngman, BS, Stephen J. Schuster, MD, Daniel J. Landsburg, MD, Sunita Dwivedy Nasta, MD, Donald Edward Tsai, MD PhD, David Michael Mintzer, MD, Jennifer Gill, NP, MSN, Colleen Dorsey, BSN, Kaitlin Kennard, RN, BSN, Elizabeth T Chatburn, BS, Joanna Rhodes, MD, Krista Isaac, DO, MS, Kristy Walsh, BS, Tanya Latorre, BSN, RN, Kaley Piersanti, BS, Evan Bannister, BS, Colleen Timlin, PharmD, BCOP, Donna Capozzi, PharmD, BCOP, Anthony R. Mato, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1575.
https://doi.org/10.1182/blood.V130.Suppl_1.1575.1575
Published: 2017
Journal Articles

Outcomes, Toxicities, and Patterns of Use of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Multicenter Retrospective Study

Steven M. Bair, MD, Lauren Elizabeth Strelec, BA, Tatyana A Feldman, MD, Nirav N Shah, MD, Nishitha Reddy, MD MSCI, MBBS, Nadia Khan, MD, Charalambos Andreadis, MD MSCE, Chaitra S. Ujjani, MD, Arun K Singavi, MD, Christina Howlett, PharmD, Khoan Vu, MD, Malik Faheem, MD, Matthew R. Youngman, BS, Sunita Dwivedy Nasta, MD, Daniel J. Landsburg, MD, Anthony R. Mato, MD, Stephen J. Schuster, MD, Jakub Svoboda, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4091.
https://doi.org/10.1182/blood.V130.Suppl_1.4091.4091
Published: 2017